Working... Menu

Exploring Asthma Exacerbations in Mepolizumab Treated Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03324230
Recruitment Status : Recruiting
First Posted : October 27, 2017
Last Update Posted : April 13, 2018
RASP (Refractory Asthma Stratification Programme)
Medical Research Council
University of Oxford
University of Leicester
NHS Greater Glasgow and Clyde
Belfast Health and Social Care Trust
Information provided by (Responsible Party):
Liam Heaney, Queen's University, Belfast

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 2020
  Estimated Study Completion Date : June 2020